Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.12.2 (
MEK
)
18,161
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Two controversies have emerged regarding the signaling pathways that regulate Golgi disassembly at the G(2)/M cell cycle transition. The first controversy concerns the role of mitogen-activated protein kinase activator
mitogen-activated protein kinase kinase
(
MEK
)1, and the second controversy concerns the participation of Golgi structure in a novel cell cycle "checkpoint." A potential simultaneous resolution is suggested by the hypothesis that
MEK1
triggers Golgi unlinking in late G(2) to control G(2)/M kinetics. Here, we show that inhibition of
MEK1
by RNA interference or by using the
MEK1
/2-specific inhibitor U0126 delayed the passage of synchronized HeLa cells into M phase. The
MEK1
requirement for normal mitotic entry was abrogated if Golgi proteins were dispersed before M phase by treatment of cells with brefeldin A or if GRASP65, which links Golgi stacks into a ribbon network, was depleted. Imaging revealed that unlinking of the Golgi apparatus begins before M phase, is independent of cyclin-dependent kinase 1 activation, and requires
MEK
signaling. Furthermore, expression of the GRASP family member
GRASP55
after alanine substitution of its
MEK1
-dependent mitotic phosphorylation sites inhibited both late G(2) Golgi unlinking and the G(2)/M transition. Thus,
MEK1
plays an in vivo role in Golgi reorganization, which regulates cell cycle progression.
...
PMID:Mitogen-activated protein kinase kinase 1-dependent Golgi unlinking occurs in G2 phase and promotes the G2/M cell cycle transition. 1718 54
Recent work indicates that
mitogen-activated protein kinase kinase
(
MEK
)1 signaling at the G2/M cell cycle transition unlinks the contiguous mammalian Golgi apparatus and that this regulates cell cycle progression. Here, we sought to determine the role in this pathway of Golgi reassembly protein (GRASP)55, a Golgi-localized target of
MEK
/extracellular signal-regulated kinase (ERK) phosphorylation at mitosis. In support of the hypothesis that
GRASP55
is inhibited in late G2 phase, causing unlinking of the Golgi ribbon, we found that HeLa cells depleted of
GRASP55
show a fragmented Golgi similar to control cells arrested in G2 phase. In the absence of
GRASP55
, Golgi stack length is shortened but Golgi stacking, compartmentalization, and transport seem normal. Absence of
GRASP55
was also sufficient to suppress the requirement for
MEK1
in the G2/M transition, a requirement that we previously found depends on an intact Golgi ribbon. Furthermore, mimicking mitotic phosphorylation of
GRASP55
by using aspartic acid substitutions is sufficient to unlink the Golgi apparatus in a gene replacement assay. Our results implicate
MEK1
/ERK regulation of
GRASP55
-mediated Golgi linking as a control point in cell cycle progression.
...
PMID:GRASP55 regulates Golgi ribbon formation. 1843 98